QuintilesIMS Announces Pricing of Secondary Public Offering


QuintilesIMS intends to repurchase from the underwriter 4,000,000 shares. QuintilesIMS is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the Selling Stockholders in the offering.



from Biotech News